5-Azacytidine and Phenylbutyrate to Treat Severe Thalassemia

NCT00005934 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Beta Thalassemia

Interventions

DRUG: 5-Azacytidine

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)